News | Radiopharmaceuticals and Tracers | September 11, 2015

Zevacor Installs First Medical-only 70 MeV Cyclotron in U.S.

Cyclone 70 to stabilize U.S. supply of Strontium 82, produce next generation of radiopharmaceutical products

Zevacor, IBA, 70 MeV cyclotron, Cyclone 70P, radiopharmaceuticals

September 11, 2015 — Zevacor Molecular (Zevacor), manufacturer and distributor of positron emission tomography (PET) and single photon emission computed tomography (SPECT) radiopharmaceuticals, announced the arrival of a 70 MeV Cyclotron at its new production facility in Noblesville, Indiana.

The 140-ton Cyclone 70P, manufactured in Belgium by Ion Beam Applications S.A (IBA), is the first commercial 70 MeV cyclotron dedicated to medical use in the United States. Expected to be fully operational in the first quarter of 2016, the cyclotron is being installed in a new, state-of-the-art high capacity manufacturing center. The center will house a complement of radioisotope synthesis equipment able to produce a broad range of radiopharmaceuticals for clinical and research applications.

The initial primary focus of the 70 MeV cyclotron will be the commercial manufacture of Strontium 82 to ensure an ample, stable U.S.-based supply of Strontium 82/Rubidium 82 generators for use in the diagnosis of cardiovascular disease. The cyclotron will also be employed to produce a wide variety of other radionuclides for both research and clinical applications.

The Cyclone 70P is an optimized, high-power proton cyclotron with variable proton acceleration in the energy range of 30 to 70 MeV. The 140-ton unit has two ports, six beam lines and capabilities for solid, liquid and gas targets.

For more information: www.iba-worldwide.com

Related Content

FDA Clears Siemens' Somatom go.All, go.Top CT Scanners
Technology | Computed Tomography (CT) | April 18, 2018
The U.S. Food and Drug Administration (FDA) has cleared the Somatom go.All and Somatom go.Top computed tomography (CT)...
Novel PET Agent Could Help Guide Therapy for Brain Diseases

Rat brain 11C‐Me‐NB1 PET images (0‐60 min) superimposed on an MRI template. Credit: SD Krämer et al., ETH Zurich, Zurich, Switzerland

News | PET Imaging | April 10, 2018
Researchers have developed a new imaging agent that could help guide and assess treatments for people with various...
The Chalk River nuclear reactor license has been renewed, but will be decommissioned by 2028.

The Chalk River nuclear isotope reactor license has been renewed, but will be decommissioned by 2028. The reactor supplies about 50 percent of the world's supply of Tc99m.

Feature | Nuclear Imaging | April 02, 2018 | Dave Fornell
April 2, 2018 – The Canadian Nuclear Safety Commission (CNSC) announced March 29 that it renewed Canadian Nuclear Lab
Edwards Completes Enrollment in PARTNER 3 Low-Risk CT Sub-Study
News | Computed Tomography (CT) | March 27, 2018
March 27, 2018 — Edwards Lifesciences Corp.
News | Ultrasound Imaging | March 21, 2018
Key processes in the body are controlled by the concentration of calcium in and around cells. A team from the Technical...
Siemens Healthineers Introduces Portable Cardiovascular-Dedicated Ultrasound at ACC.18
News | Cardiovascular Ultrasound | March 13, 2018
At the American College of Cardiology’s (ACC) 67th Annual Scientific Session and Expo, March 10-12 in Orlando, Fla.,...
The yellow in the anterolateral entorhinal cortex of the young brain indicates significant activity, something that is absent in the older brain.

This figure shows two different brains that are aligned to a common template space for comparison. The yellow in the anterolateral entorhinal cortex of the young brain indicates significant activity, something that is absent in the older brain. CREDIT: Zachariah Reagh

News | Nuclear Imaging | March 08, 2018
As we get older, it's not uncommon to experience "senior moments," in which we forget where we parked our car or call...
ASE Participating in Global Study to Establish New Standardization in Cardiovascular Ultrasound
News | Cardiovascular Ultrasound | February 26, 2018
February 26, 2018 – The American Society of Echocardiography (ASE) and its International Alliance Partners are joinin
Axumin PET Agent Added to NCCN Guidelines for Suspected Recurrent Prostate Cancer
News | PET Imaging | February 21, 2018
Blue Earth Diagnostics announced that Axumin (fluciclovine F 18) injection has been added to the National Comprehensive...
Overlay Init